HNSA.ST
Hansa Biopharma AB (publ)
StockholmSEKEQUITY
Healthcare
DELAYED
Last price
41.74
▲ 1.10 (2.71%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
41.00
Prev close
40.64
Day high
41.94
Day low
40.22
Volume
528.79K
Market cap
$4.16B
P/E (TTM)
—
52W range
23.52 – 43.80
Day trading desk
Gap from prior close
+0.89%
Prior close 40.64
VWAP
41.27
+1.14% from price
Relative volume
2.90×
Unusually busy
Session range
4.28%
40.22 – 41.94
Position in range
88%
Near session high
ATR (14D)
2.31
5.54% of price
Prior day high
42.66
PDH
Prior day low
40.48
PDL
Bid / ask spread
—
Quote not published
Session volume
1.68M
Avg 578.47K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+6.59%
+8.0%
1M
+35.96%
+32.2%
3M
+21.27%
+18.2%
6M
+26.48%
+15.4%
YTD
+21.48%
+9.2%
1Y
+31.67%
+11.7%
3Y
-11.94%
-86.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on HNSA.ST open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
6.30M
Total on file
Fundamentals
Market cap$4.16B
Enterprise value$4.73B
Revenue (TTM)$189.46M
Gross profit$108.32M
EBITDA$-570.37M
Net income$-755.14M
EPS (TTM)$-7.65
Free cash flow$-268.46M
Total cash$552.81M
Total debt$1.03B
Book value / share$-5.11
Shares outstanding99.73M
Float65.80M
Short % of float—
Dividend yield—
Beta (5Y)1.58
Valuation & profitability ratios
Trailing P/E—
Forward P/E-5.66
PEG ratio—
Price / sales—
Price / book—
EV / revenue24.96
EV / EBITDA-8.29
Gross margin57.17%
Operating margin-334.87%
Profit margin0.00%
Return on equity—
Return on assets-37.83%
Debt / equity—
Current ratio1.25
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $222.26M | $171.32M | $134.09M | $154.53M | +29.7% |
| Operating revenue | $222.26M | $171.32M | $134.09M | $154.53M | +29.7% |
| Cost of revenue | $83.56M | $83.55M | $63.14M | $38.48M | +0.0% |
| Gross profit | $138.71M | $87.76M | $70.95M | $116.05M | +58.0% |
| Research & development | $304.74M | $375.72M | $411.33M | $346.24M | -18.9% |
| Selling, general & admin | $356.55M | $344.27M | $450.49M | $337.86M | +3.6% |
| Total operating expense | $656.50M | $719.40M | $862.11M | $692.17M | -8.7% |
| Operating income | -$517.80M | -$631.64M | -$791.16M | -$576.12M | +18.0% |
| Net interest income | -$114.68M | -$101.60M | -$77.53M | -$34.83M | -12.9% |
| Pre-tax income | -$531.84M | -$804.21M | -$830.81M | -$609.98M | +33.9% |
| Tax provision | $2.27M | $3.03M | $908.00K | $1.16M | -25.2% |
| Net income | -$534.11M | -$807.24M | -$831.72M | -$611.13M | +33.8% |
| Net income to common | -$534.11M | -$807.24M | -$831.72M | -$611.13M | +33.8% |
| Basic EPS | -6.58 | -12.85 | -15.83 | -13.60 | +48.8% |
| Diluted EPS | -6.58 | -12.85 | -15.83 | -13.60 | +48.8% |
| EBIT | -$409.91M | -$670.13M | -$725.29M | -$566.31M | +38.8% |
| EBITDA | -$371.15M | -$642.07M | -$705.50M | -$554.26M | +42.2% |
| Basic shares | 81.20M | 62.83M | 52.54M | 44.92M | +29.2% |
| Diluted shares | 81.20M | 62.83M | 52.54M | 44.92M | +29.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $701.08M | $405.28M | $732.06M | $1.50B | +73.0% |
| Cash & short-term investments | $701.08M | $405.28M | $732.06M | $1.50B | +73.0% |
| Accounts receivable | $53.87M | $26.78M | $76.27M | $8.36M | +101.2% |
| Inventory | $6.13M | $2.61M | $1.51M | $973.00K | +134.9% |
| Total current assets | $796.61M | $467.24M | $855.15M | $1.60B | +70.5% |
| Property, plant & equipment | $13.35M | $17.88M | $27.07M | $35.84M | -25.4% |
| Goodwill & intangibles | $230.56M | $197.33M | $135.82M | $46.87M | +16.8% |
| Total assets | $1.17B | $800.64M | $1.02B | $1.69B | +45.7% |
| Total current liabilities | $410.66M | $255.69M | $320.99M | $264.71M | +60.6% |
| Current debt | $136.87M | $0 | — | — | — |
| Long-term debt | $790.53M | $1.06B | $844.90M | $762.60M | -25.7% |
| Total debt | $938.67M | $1.08B | $866.77M | $791.09M | -13.0% |
| Total liabilities | $1.26B | $1.39B | $1.19B | $1.08B | -9.7% |
| Retained earnings | -$4.64B | -$4.11B | -$3.30B | -$2.47B | -13.0% |
| Shareholder equity | -$88.99M | -$589.83M | -$167.88M | $602.91M | +84.9% |
| Working capital | $385.95M | $211.56M | $534.16M | $1.34B | +82.4% |
| Net tangible assets | -$319.55M | -$787.17M | -$303.69M | $556.05M | +59.4% |
| Shares issued | 101.76M | 67.81M | 55.03M | 55.03M | +50.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$534.11M | -$807.24M | -$831.72M | -$611.13M | — | +33.8% |
| Depreciation & amortisation | $38.76M | $28.06M | $19.79M | $12.05M | — | +38.1% |
| Change in working capital | -$37.60M | -$64.03M | $11.44M | $21.43M | — | +41.3% |
| Operating cash flow | -$549.17M | -$674.88M | -$755.65M | -$502.73M | — | +18.6% |
| Capital expenditure | — | -$116.00K | -$284.00K | -$3.33M | -$2.40M | — |
| Investing cash flow | $0 | -$116.00K | -$284.00K | $229.31M | — | +100.0% |
| Financing cash flow | $847.96M | $346.81M | -$7.54M | $1.12B | — | +144.5% |
| Free cash flow | -$549.17M | -$675.00M | -$755.94M | -$506.06M | — | +18.6% |
| End cash position | $701.08M | $405.28M | $732.06M | $1.50B | — | +73.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $48.10M | $34.57M | $75.99M | $49.12M | $66.35M | +39.1% |
| Operating revenue | $48.10M | $34.57M | $75.99M | $49.12M | $66.35M | +39.1% |
| Cost of revenue | $22.33M | $13.78M | $24.66M | $18.02M | $20.51M | +62.1% |
| Gross profit | $25.77M | $20.79M | $51.34M | $31.11M | $45.84M | +23.9% |
| Research & development | $67.87M | $57.34M | $74.43M | $95.84M | $64.26M | +18.4% |
| Selling, general & admin | $118.93M | $105.56M | $101.62M | $90.52M | $75.99M | +12.7% |
| Total operating expense | $199.83M | $163.30M | $176.25M | $185.62M | $139.24M | +22.4% |
| Operating income | -$174.06M | -$142.50M | -$124.91M | -$154.52M | -$93.40M | -22.1% |
| Net interest income | -$55.27M | -$53.36M | -$39.73M | $17.83M | $54.89M | -3.6% |
| Pre-tax income | -$259.86M | -$195.87M | -$164.64M | -$196.13M | -$38.51M | -32.7% |
| Tax provision | $677.00K | $453.00K | $396.00K | $842.00K | $337.00K | +49.4% |
| Net income | -$260.54M | -$196.32M | -$165.04M | -$196.97M | -$38.85M | -32.7% |
| Net income to common | -$260.54M | -$196.32M | -$165.04M | -$196.97M | -$38.85M | -32.7% |
| Basic EPS | -2.56 | -1.93 | -1.62 | -2.78 | -0.57 | -32.6% |
| Diluted EPS | -2.56 | -1.93 | -1.62 | -2.78 | -0.57 | -32.6% |
| EBIT | -$201.38M | -$139.95M | -$100.05M | -$164.47M | -$7.24M | -43.9% |
| EBITDA | -$189.72M | -$139.95M | -$100.05M | -$154.97M | -$7.24M | -35.6% |
| Basic shares | 101.76M | 101.76M | 101.76M | 70.80M | 67.81M | 0.0% |
| Diluted shares | 101.76M | 101.76M | 101.76M | 70.80M | 67.81M | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $552.81M | $676.46M | $701.08M | $354.42M | $250.20M | — | -18.3% |
| Cash & short-term investments | $552.81M | $676.46M | $701.08M | $354.42M | $250.20M | — | -18.3% |
| Accounts receivable | $65.98M | $70.16M | $53.87M | $181.32M | $183.57M | — | -6.0% |
| Inventory | $7.96M | $6.04M | $6.13M | $2.94M | $2.89M | — | +31.8% |
| Total current assets | $690.95M | $794.30M | $796.61M | $578.91M | $475.48M | — | -13.0% |
| Property, plant & equipment | $8.04M | $10.66M | $13.35M | $13.86M | $16.19M | — | -24.6% |
| Goodwill & intangibles | $247.05M | $234.27M | $230.56M | $244.50M | $213.58M | — | +5.5% |
| Total assets | $1.07B | $1.16B | $1.17B | $837.27M | $705.25M | — | -7.9% |
| Total current liabilities | $554.39M | $218.84M | $410.66M | $422.07M | $259.57M | — | +153.3% |
| Current debt | $300.85M | — | $136.87M | $141.47M | — | $0 | — |
| Long-term debt | $726.45M | $1.13B | $790.53M | $753.64M | $1.01B | — | -35.9% |
| Total debt | $1.03B | $1.14B | $938.67M | $906.21M | $1.02B | — | -9.5% |
| Total liabilities | $1.59B | $1.44B | $1.26B | $1.28B | $1.33B | — | +10.7% |
| Retained earnings | — | — | -$4.64B | — | — | -$4.11B | — |
| Shareholder equity | -$520.24M | — | -$88.99M | -$441.06M | -$623.74M | -$589.83M | — |
| Working capital | $136.55M | $575.46M | $385.95M | $156.84M | $215.91M | — | -76.3% |
| Net tangible assets | -$767.29M | — | -$319.55M | -$685.55M | -$837.32M | -$787.17M | — |
| Shares issued | 101.76M | 101.76M | 101.76M | 84.76M | 67.81M | — | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$174.06M | -$196.32M | -$165.04M | -$154.52M | -$38.85M | +11.3% |
| Depreciation & amortisation | $11.67M | — | — | $9.50M | — | — |
| Change in working capital | $36.61M | -$40.05M | -$75.48M | $62.73M | -$42.15M | +191.4% |
| Operating cash flow | -$103.50M | -$156.98M | -$177.54M | -$94.19M | -$151.87M | +34.1% |
| Capital expenditure | -$18.54M | — | — | -$17.51M | -$628.00K | — |
| Investing cash flow | -$18.54M | $0 | $0 | -$17.51M | $0 | — |
| Financing cash flow | -$2.07M | $131.96M | $627.58M | $216.53M | -$1.93M | -101.6% |
| Free cash flow | -$122.05M | -$156.98M | -$177.54M | -$111.70M | -$151.87M | +22.3% |
| End cash position | $552.81M | $676.46M | $701.08M | $354.42M | $250.20M | -18.3% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.30 | -2.26 | -660.7% |
| Mar 2026 | -1.45 | -1.93 | -33.4% |
| Dec 2025 | -1.66 | -1.62 | +2.4% |
| Sep 2025 | -1.85 | -1.75 | +5.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 5.35 | 2 | $686.68M | +2,129.2% |
| Next quarter | 2.40 | 1 | $219.56M | +188.9% |
| Current year | 1.50 | 3 | $952.01M | +328.3% |
| Next year | -5.54 | 6 | $438.25M | -54.0% |
Analyst targets & ownership
Mean target$73.00
High target$103.00
Low target$36.00
Implied upside74.89%
Analyst count8
ConsensusNONE
Strong buy / Buy0 / 7
Hold1
Sell / Strong sell0 / 0
Held by insiders6.19%
Held by institutions48.56%
Institutions holding20
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
40.84
+2.21% from price
SMA 20
38.40
+8.71% from price
SMA 50
35.61
+17.22% from price
SMA 100
32.93
+26.74% from price
SMA 200
32.65
+27.83% from price
EMA 12
40.09
+4.12% from price
EMA 26
38.14
+9.43% from price
EMA 50
36.24
+15.17% from price
RSI (14)
62.5
Neutral
MACD (12,26,9)
1.94
Hist 0.23
ATR (14)
2.31
5.54% of price
Realised vol 30D
90.5%
Annualised
Bollinger upper
44.39
20, 2σ
Bollinger lower
32.40
20, 2σ
50 / 200 cross
Golden
35.61 vs 32.65
Trend bias
Above 200
+27.83%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.27
Less volatile than market
Correlation to SPY
-0.05
Largely independent
Realised vol 30D
90.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-41.8%
Peak to trough
Max drawdown 5Y
-84.5%
Peak to trough
ATR 14
2.31
5.54% of price
Beta (reported)
1.58
5Y monthly, from filing
Headlines
Nervous About the Stock Market? History Has Encouraging News for Long-Term Investors.
Motley Fool · 9m ago
Johnson & Johnson (JNJ) Wins EU Approval For TECVAYLI Combo In Multiple Myeloma
Simply Wall St. · 16m ago
Will Alaska Air (ALK)ʼs New Seattle–Europe Routes Redefine Its International Growth Narrative?
Simply Wall St. · 16m ago
Traeger (COOK) Stock Fair Value Rises After Q2 Margin Strength Lifts Analyst Targets
Simply Wall St. · 16m ago
Cigna Group (CI) Could Be 19% Undervalued As AI Spotlight Meets Growth Narrative
Simply Wall St. · 17m ago
Is Excelerate Energy (EE) Still Below Fair Value Following Its Recent Rally?
Simply Wall St. · 17m ago
Kane voted German footballer of the year
AFP · 18m ago
Asphalt Expert Robert Stewart Explains Asphalt Driveway Installation Preparation in HelloNation
PR Newswire · 20m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.